We are live on ! Find out more
173.90 USD
+10.00
6.1%
At close Updated Sep 24, 4:00 PM EDT
Pre-market
After hours
173.90
0.00
0%
1 day
6.1%
5 days
2.6%
1 month
0.24%
3 months
9.94%
6 months
71.7%
Year to date
-7.83%
1 year
3.83%
5 years
-38.56%
10 years
128.85%
 

About: Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Employees: 40,100

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 50%
Negative 16.7%
Positive
Zacks Investment Research
27 days ago
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Icon PLC (ICLR) reported earnings 30 days ago. What's next for the stock?
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Positive
Seeking Alpha
1 month ago
Oakmark Concentrated Strategy Q2 2026 Performance Review
The portfolio's return was 9.21% (net) for the reporting period. Centene, ICON and Keurig Dr Pepper were the contributors during the quarter. Intercontinental Exchange, Salesforce and ConocoPhillips were the detractors during the quarter.
Oakmark Concentrated Strategy Q2 2026 Performance Review
Neutral
Zacks Investment Research
1 month ago
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
ICLR's discounted valuation and $23.4B backlog support upside potential, but falling estimates, weaker margins and execution risks argue for patience.
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Positive
Zacks Investment Research
1 month ago
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
ICON's 33.2% rally is backed by stronger proposal flow, bookings and backlog, but weaker earnings and margins cloud the recovery.
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
Neutral
Business Wire
1 month ago
ICON Announces Private Offering of Notes
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading clinical research organization, announced today that its wholly-owned subsidiary, ICON Investments Six Designated Activity Company (the “Issuer”), intends to offer one or more series of senior notes (the “Notes”), in a private offering (the “Offering”) with registration rights, subject to market and other conditions. The Notes will be guaranteed on a senior unsecured basis by ICON.
ICON Announces Private Offering of Notes
Neutral
Business Wire
1 month ago
ICON Announces Results of Annual General Meeting
DUBLIN--(BUSINESS WIRE)--ICON Announces Results of Annual General Meeting.
ICON Announces Results of Annual General Meeting
Neutral
Seeking Alpha
1 month ago
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
ICON Public Limited Company (ICLR) Q2 2026 Earnings Call Transcript
Negative
MarketBeat
1 month ago
Icon Q2 Earnings Call Highlights
Icon NASDAQ: ICLR reported second-quarter 2026 revenue growth and strong bookings as higher pass-through activity supported the top line, while the company continued to manage business-mix pressures affecting reported margins.
Icon Q2 Earnings Call Highlights
Negative
Zacks Investment Research
1 month ago
Icon PLC (ICLR) Lags Q2 Earnings Estimates
Icon PLC (ICLR) came out with quarterly earnings of $2.56 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $3.26 per share a year ago.
Icon PLC (ICLR) Lags Q2 Earnings Estimates
Neutral
Business Wire
1 month ago
ICON Reports Second Quarter 2026 Results
DUBLIN--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today reported its financial results for the second quarter ended June 30, 2026.
ICON Reports Second Quarter 2026 Results
Price charts implemented using Lightweight Charts™